The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic impact of bone marrow involvement for patients with diffuse large B-cell lymphoma in the era of rituximab.
B. W. Kang
No relevant relationships to disclose
Y. J. Lee
No relevant relationships to disclose
Y. S. Chae
No relevant relationships to disclose
J. H. Moon
No relevant relationships to disclose
J. G. Kim
No relevant relationships to disclose
S. K. Sohn
No relevant relationships to disclose
J. S. Suh
No relevant relationships to disclose
T. I. Park
No relevant relationships to disclose
M. K. Kim
No relevant relationships to disclose
M. S. Hyun
No relevant relationships to disclose
H. J. Kim
No relevant relationships to disclose
J. Lee
No relevant relationships to disclose
D. H. Yang
No relevant relationships to disclose
S. H. Bae
No relevant relationships to disclose
H. Ryoo
No relevant relationships to disclose
K. Y. Kwon
No relevant relationships to disclose
J. Y. Kim
No relevant relationships to disclose
Y. R. Do
No relevant relationships to disclose
K. U. Park
No relevant relationships to disclose
H. Kim
No relevant relationships to disclose